BioSpace News Archive

Pharm Country

Ophthalmic Drugs Market to become worth US$34.3 bn by 2025, Says TMRGlobal Ophthalmic Drugs Market: Innovations and Developments to Encourage Growth

According to the market research study, in 2016, the global ophthalmic drugs market was worth US$24.4 bn and is estimated to reach a value of US$34.3 bn by the end of 2025.

July 5, 2018
·
4 min read
Drug Development

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Corp. announces that patient screening and recruitment has begun in its regenerative medicine US clinical trial for diabetic patients with hypoglycemia unawareness.

July 5, 2018
·
5 min read
Business

Amarantus Provides Update on Elto Pharma Capital Formation Plan

Amarantus Bioscience Holdings, Inc. provided an update to the marketplace on its capital formation plans for its wholly-owned subsidiary Elto Pharma, Inc.

July 5, 2018
·
4 min read
Business

The American Health Council Selects Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to Industry Board

The American Health Council selected Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to its Industry Board.

July 5, 2018
·
5 min read
Drug Development

International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson’s Disease Clinical Trial

International Stem Cell Corporation announced that the first patient of the third cohort of the clinical trial for Parkinson’s disease was successfully transplanted with 70,000,000 ISC-hpNSC®.

July 5, 2018
·
7 min read
Business

Daxor Corporation Appoints Kathryn A. Kornafel Vice President of Marketing and Commercial Development

Daxor Corporation announces the appointment of Kathryn A. Kornafel as vice president of Marketing and Commercial Development.

July 5, 2018
·
3 min read
Business

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2018 and Provides Conference Call InformationConference Call Scheduled for Friday, June 15 at 1:00 PM EDT

Elite Pharmaceuticals, Inc. announced results for the fiscal year ended March 31, 2018

July 5, 2018
·
4 min read
Pharm Country

Cognition Therapeutics Initiates NIA-Funded SPARC Study of Elayta™ to Assess Changes in Synaptic Density and Cognitive Performance in Alzheimer’s DiseaseFirst Longitudinal Study of Novel Synaptic Imaging Agent

Cognition Therapeutics, Inc. announced that patient dosing has begun in the SPARC (Synaptic Protection for Alzheimer’s Restoration of Cognition) study of Elayta™ (CT1812), Cognition’s lead candidate for the treatment of mild-to-moderate Alzheimer’s disease.

July 5, 2018
·
4 min read
Business

Therapeutic Solutions International Announces the Appointment of James Veltmeyer, MD as Chief Medical Officer

Therapeutics Solutions International, Inc. announced their plans to provide access to its clinical stage cancer immunotherapy product StemVacs under the Right To Try law signed by President Trump on May 30th 2018, and have appointed Dr. James Veltmeyer as Chief Medical Officer of their future planned cancer clinic.

July 5, 2018
·
3 min read
InspireMD’s CGuard EPS Prominently Featured at the 10th International Congress of the Polish Society for Vascular Surgery

Study results presented from 46 patients treated over two years with zero complications

July 5, 2018
·
5 min read